Language Select
Varian Logo

Recent News

April 20, 2018
Varian (NYSE: VAR) today announced it has received FDA 510(k) clearance for its Calypso® Anchored Beacon® transponder. Used with a Varian TrueBeam®, Edge® and Clinac® C-series medical linear... Read more
April 19, 2018
Varian (NYSE: VAR) today announced it will be showcasing the expanded imaging and treatment capabilities of the Halcyon™ system and the new version of the Velocity™ cancer imaging software,... Read more
April 19, 2018
Varian (NYSE: VAR) today announced it is incorporating new imaging technologies in the Halcyon™ 2.0 treatment system to expand its capabilities and ability to deliver high quality cancer care... Read more

Recent Blog Posts

Apr 06, 2018 | Centerline
The ARIA® oncology information system (OIS) version 15.5 was recently named a Category Leader in the 2018 Best in KLAS: Software and Services Report by KLAS, an independent research firm specializing... Read more
Feb 16, 2018 | Centerline
Researchers have reported that cervical cancer patients who are treated with combined external beam radiotherapy (EBRT) and brachytherapy appear to have a significantly better overall survival... Read more
Jan 03, 2018 | Spot ON Blog
Proton-Man symbolizes the determination and technology that doctors employ when they utilize proton therapy to fight cancer. Proton-Man's mission is to spread the word about proton therapy and... Read more

Get News Releases by Email
Subscribe Now

Corporate Communications Contact

Mark Plungy
Director, Public Relations
650.424.5630
[email protected]

Investor Relations Contact

Mike Bruff
SVP, Investor Relations
650.424.5163
[email protected]

Monica Prokocki
Director, Investor Relations
650.424.5184
[email protected]